Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Disposal of Warrants

17 Jun 2016 07:00

RNS Number : 4800B
Highlands Natural Resources PLC
17 June 2016
 

Highlands Natural Resources plc ('Highlands' or 'the Company')

Update on Disposal of Warrants

 

Highlands, the London listed natural resources company, announces that it has been notified by Diversion Technologies LLC ('Diversion') that the arrangements entered into by Diversion earlier this week to sell its entire holding of 30 million warrants in Highlands to an institutional investor (the 'Institutional Investor') have been altered slightly as a reflection of the recent movements in the Highlands share price. These alterations affect only Diversion. The effect of the transaction on Highlands is unchanged, namely that, if the Institutional Investor takes up its options to acquire Diversion's entire holding and exercises the warrants, Highlands will receive new funds of £7.5 million.

 

The purchase price of the first 10 million of these warrants has been reduced to 1 pence per warrant, payable to Diversion. Furthermore, Diversion has notified Highlands that these 10 million warrants have now been acquired at that price by the Institutional Investor. On the assumption that the Institutional Investor exercises those warrants in due course, then Highlands will receive new funds of £2.5 million.

 

In return for accepting a lesser price for the first 10 million warrants, the options that the Institutional Investor has to acquire Diversion's remaining 20 million warrants have been re-priced in Diversion's favour. These warrants can be acquired at a price equal to 10 pence per warrant plus 50 per cent. of any amount by which the Highlands share price on the day prior to exercise exceeds 51 pence. All other terms of the arrangements remain as previously announced.

 

Robert Price, Chairman of Highlands, has a beneficial interest in the warrants which are the subject of these arrangements as a 37.5 per cent. shareholder in Diversion.

 

This has been a very active week for Highlands with the announcement of two significant transactions as well as the release of our annual results. The Board has received a number of investor inquiries requesting further information on Highlands' activities and has therefore produced a Q&A in response to these which will be available on the Company's website at http://www.highlandsnr.com at 9.30am this morning.

 

Highlands CEO Robert Price said, "This transaction by Diversion provides three significant advantages for Highlands. Firstly, if all the warrants are exercised, the potential new funds for Highlands of £7.5 million are more than the Company has raised in aggregate to date. Secondly, the sale rebalances our capital structure, making the Company easier to value. Finally, and related to this, the exercise of the warrants would increase the Company's size and liquidity which in turn should enhance our appeal to a wider investor audience.

 

"Highlands is grateful to Diversion for entering into these arrangements. As I outlined above, the effect should be to increase the funds available to Highlands so, the sale, and potential exercise of the warrants will reduce our reliance on future third party funding which itself is uncertain both in availability in price. "With these arrangements in place, we now have the opportunity to accelerate Highlands' core projects, including the deployment of DT Ultravert."

 

Notes

 

The 30 million warrants were granted to Diversion by Highlands in May last year as part of the consideration to acquire a 75% interest in the pending patents for DT Ultravert, which has the potential to transform and significantly reduce the costs associated with unconventional exploration and production via re-fracking. Pursuant to that transaction, Diversion was also issued with 1.9 million ordinary shares in Highlands which it continues to hold. The warrants are exercisable into ordinary shares in Highlands at 25 pence per share at any time up to 29 May 2018.

 

 

**ENDS**

 

For further information, please contact:

 

 

Highlands Natural Resources plc

Robert Price

+1 (0) 918 361 7000

Cenkos Securities plc

Neil McDonald

+44 (0)131 220 9771

Nick Tulloch

+44 (0)131 220 9772

St Brides Partners Ltd

Lottie Brocklehurst

+44 (0) 20 7236 1177

Elisabeth Cowell

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISFFMPTMBIBBAF
Date   Source Headline
16th Aug 20217:00 amRNSChange of Name
3rd Aug 20214:00 pmRNSNotice of Results
30th Jul 20213:30 pmRNSHolding(s) in Company
29th Jul 20217:00 amRNSBusiness Update
8th Jul 20212:05 pmRNSSecond Price Monitoring Extn
8th Jul 20212:00 pmRNSPrice Monitoring Extension
1st Jul 20217:00 amRNSBusiness Update
7th Jun 20214:40 pmRNSSecond Price Monitoring Extn
7th Jun 20214:35 pmRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSHolding(s) in Company
1st Jun 20217:00 amRNSIssue of Warrants
28th May 20215:00 pmRNSTotal Voting Rights
17th May 20217:00 amRNSUpdate on ‘Chill’ orders
4th May 20217:00 amRNSSubscription raises £6m, LDA financing cancelled
30th Apr 20215:00 pmRNSTotal Voting Rights
16th Apr 20217:00 amRNSTrading Update
12th Apr 20217:00 amRNSHolding(s) in Company
6th Apr 20217:00 amRNSNovel Food Application
31st Mar 20215:00 pmRNSTotal Voting Rights
31st Mar 20217:00 amRNSIssue of Shares
25th Mar 20217:00 amRNSExercise of Share Options
15th Mar 20212:30 pmRNSHolding(s) in Company
9th Mar 20219:06 amRNSSecond Price Monitoring Extn
9th Mar 20219:00 amRNSPrice Monitoring Extension
9th Mar 20217:00 amRNSFinancing Agreement with LDA Capital
8th Mar 20212:45 pmRNSHolding(s) in Company
2nd Mar 20213:00 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSUS Distribution Update
15th Feb 20217:00 amRNSProgress Update
3rd Feb 20219:05 amRNSSecond Price Monitoring Extn
3rd Feb 20219:00 amRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSInterim Results
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
8th Jan 20217:00 amRNSCommencement of trading on the OTCQX
31st Dec 20207:00 amRNSUpdate on Sale of DTU
22nd Dec 20204:36 pmRNSPrice Monitoring Extension
16th Dec 20202:05 pmRNSSecond Price Monitoring Extn
16th Dec 20202:00 pmRNSPrice Monitoring Extension
10th Dec 20206:00 pmRNSHolding(s) in Company
10th Dec 20206:00 pmRNSHolding(s) in Company
9th Dec 202010:00 amRNSHolding(s) in Company
8th Dec 202011:05 amRNSSecond Price Monitoring Extn
8th Dec 202011:00 amRNSPrice Monitoring Extension
8th Dec 20209:05 amRNSSecond Price Monitoring Extn
8th Dec 20209:00 amRNSPrice Monitoring Extension
30th Nov 20205:00 pmRNSTotal Voting Rights
27th Nov 202011:06 amRNSSecond Price Monitoring Extn
27th Nov 202011:00 amRNSPrice Monitoring Extension
24th Nov 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.